A green and practical strategy for therapeutic drug monitoring of teicoplanin A2 components in human plasma using functionalized liquid film solvent bar microextraction coupled with high-performance liquid chromatography–ultraviolet detection
Journal of Chromatography A · 2026
DOI: 10.1016/j.chroma.2026.466673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography A, 2026. Verfasst von Jie Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, First Hospital of Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Teicoplanin, Liquid Phase Microextraction, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Shanxi Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
A novel functionalized liquid film solvent bar microextraction (FLF-SBME) method coupled with high-performance liquid chromatography-ultraviolet detection (HPLC/UV) was developed for the extraction and subsequent determination of five A2-components of teicoplanin, TA2-1, TA2-2, TA2-3, TA2-4 and TA2-5, simultaneously in human plasma. The microextraction mechanism of FLF-SBME was systematically elucidated, in which tri-n-octyl methyl ammonium chloride (TOMAC) was employed to modify polypropylene hollow fibers (PP-HFs), enabling efficient enrichment and separation of the target analytes from plasma. The key extraction parameters influencing efficiency were thoroughly optimized. Under optimal conditions, the method provided high enrichment factors (36-59) for all five A2 components, along with good linearity (1.0-110 µg/mL; r > 0.99), limits of detection of 0.5-3.0 µg/mL, and lower limits of quantification of 1.0-5.0 µg/mL. The intra- and inter-day precision (RSD < 12.2 %) and accuracy (recoveries: 91.5-110.3 %) were satisfactory. With its notable enrichment capability, high selectivity, sensitivity, and reliability, the proposed FLF-SBME-HPLC/UV method is well-suited for the monitoring of teicoplanin in human plasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
- Linfen People's Hospital, Linfen 041000, China.
- School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China.
- School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China. Electronic address: ywfxcx@163.com.
Förderung
- Shanxi Medical University
- National Natural Science Foundation of China
Zitieren
APA
Tian, J., Zhang, Y. F., Sun, Y. F., Yan, D., Hu, S., Xing, R. R., Wang, R. Q., Yang, L., & Chen, X. (2026). A green and practical strategy for therapeutic drug monitoring of teicoplanin A2 components in human plasma using functionalized liquid film solvent bar microextraction coupled with high-performance liquid chromatography–ultraviolet detection. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2026.466673
Vancouver
Tian J, Zhang YF, Sun YF, Yan D, Hu S, Xing RR, et al. A green and practical strategy for therapeutic drug monitoring of teicoplanin A2 components in human plasma using functionalized liquid film solvent bar microextraction coupled with high-performance liquid chromatography–ultraviolet detection. Journal of Chromatography A. 2026. doi:10.1016/j.chroma.2026.466673
BibTeX
@article{Tian2026,
author = {Tian, Jie and Zhang, Yi-Fang and Sun, Yu-Feng and Yan, Dou and Hu, Shuang and Xing, Rong-Rong and Wang, Run-Qin and Yang, Li and Chen, Xuan},
title = {A green and practical strategy for therapeutic drug monitoring of teicoplanin A2 components in human plasma using functionalized liquid film solvent bar microextraction coupled with high-performance liquid chromatography–ultraviolet detection},
journal = {Journal of Chromatography A},
year = {2026},
doi = {10.1016/j.chroma.2026.466673}
}
EUVIMED